Evidence map›Paper›PMID 34274495›Full record

ArticleContemporary clinical trials2021

Effect of healthy diet and exercise on chemotherapy completion rate in women with breast cancer: The Lifestyle, Exercise and Nutrition Early after Diagnosis (LEANer) study: Study protocol for a randomized clinical trial.

Tara Sanft, Maura Harrigan, Brenda Cartmel, Leah M Ferrucci, Fang-Yong Li, Courtney McGowan, Michelle Zupa, Thai Hien Nguyen, Jennifer Ligibel, Marian L Neuhouser and 7 more

Open access · hybridAbstract readClinical Trial Protocol
In one paragraph

Article in Contemporary clinical trials, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 16 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 6 institutions in 1 country.

Tara SanftYale University School of Medicine, New Haven, CT, United States of America; Yale Cancer Center, New Haven, CT, United States of America. Electronic address: tara.sanft@yale.edu.
Maura HarriganYale University School of Public Health, New Haven, CT, United States of America. Electronic address: maura.harrigan@yale.edu.
Brenda CartmelYale University School of Public Health, New Haven, CT, United States of America; Yale Cancer Center, New Haven, CT, United States of America. Electronic address: brenda.cartmel@yale.edu.
Leah M FerrucciYale University School of Public Health, New Haven, CT, United States of America; Yale Cancer Center, New Haven, CT, United States of America. Electronic address: leah.ferrucci@yale.edu.
Fang-Yong LiYale University School of Public Health, New Haven, CT, United States of America. Electronic address: fang-yong.li@yale.edu.
Courtney McGowanYale University School of Public Health, New Haven, CT, United States of America. Electronic address: courtney.mcgowan@yale.edu.
Michelle ZupaYale University School of Public Health, New Haven, CT, United States of America. Electronic address: michelle.zupa@yale.edu.
Thai Hien NguyenYale University School of Public Health, New Haven, CT, United States of America. Electronic address: thaihien.nguyen@yale.edu.
Jennifer LigibelDana-Farber Cancer Institute, Boston, MA, United States of America. Electronic address: ligibel@dfci.harvard.edu.
Marian L NeuhouserFred Hutchinson Cancer Research Center, Seattle, WA, United States of America. Electronic address: mneuhous@fredhutch.org.
Dawn L HershmanColumbia University Medical Center, New York, NY, United States of America. Electronic address: dlh23@cumc.columbia.edu.
Karen Basen-EngquistThe University of Texas MD Anderson Cancer Center, Houston, TX, United States of America. Electronic address: kbasenen@mdanderson.org.
Beth JonesYale University School of Public Health, New Haven, CT, United States of America; Yale Cancer Center, New Haven, CT, United States of America. Electronic address: beth.jones@yale.edu.
Tish KnobfYale Cancer Center, New Haven, CT, United States of America; Yale School of Nursing, New Haven, CT, United States of America. Electronic address: tish.knobf@yale.edu.
Anees ChagparYale University School of Medicine, New Haven, CT, United States of America; Yale Cancer Center, New Haven, CT, United States of America. Electronic address: anees.chagpar@yale.edu.
Andrea SilberYale University School of Medicine, New Haven, CT, United States of America; Yale Cancer Center, New Haven, CT, United States of America. Electronic address: andrea.silber@yale.edu.
Melinda L IrwinYale University School of Public Health, New Haven, CT, United States of America; Yale Cancer Center, New Haven, CT, United States of America. Electronic address: melinda.irwin@yale.edu.
Yale University · USYale Cancer Center · USColumbia University Irving Medical Center · USDana-Farber Cancer Institute · USFred Hutch Cancer Center · USThe University of Texas MD Anderson Cancer Center · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Yale Pathology Tissue Services Shared ResourceP30CA016359 · NCI · YALE UNIVERSITY · PI MEGAN C KING · 1985 to 2026
$85.0M
Yale University Clinical and Translational Science Award ProgramUL1TR000142 · NCATS · YALE UNIVERSITY · PI SHERWIN, ROBERT S · 2012 to 2015
$31.8M
ZIPRASIDONE IN TOURETTES SYNDROME, OBSESSIVE COMPULSIVE &PERVASIVE DEV. DISORDERM01RR000125 · NCRR · YALE UNIVERSITY · PI ALPERN, ROBERT J · 1985 to 2006
$24.1M
A randomized trial of lifestyle guidelines on breast cancer biomarkers and treatment adherenceR01CA207753 · NCI · YALE UNIVERSITY · PI IRWIN, MELINDA L, SANFT, TARA B · 2017 to 2021
$3.5M
Cancer Screening Behavior in Hispanic/Latinas Living in the Northeast United StatR01CA134276 · NCI · YALE UNIVERSITY · PI JONES, BETH A · 2008 to 2012
$3.3M
NCATS NIH HHS UL1 TR000142NCATS NIH HHS UL1 TR001863NCI NIH HHS P30 CA016359NCI NIH HHS R01 CA134276NCI NIH HHS R01 CA207753NCRR NIH HHS M01 RR000125
6 · The paper itself

Abstract

backgroundThe World Cancer Research Fund and the American Cancer Society provide nutrition and physical activity guidelines for cancer survivors. Many women with breast cancer do not follow these guidelines and delay efforts toward following them until active treatment is complete. However, adoption of these recommended lifestyle behaviors soon after diagnosis may prevent adverse treatment-related side effects and may improve adherence to treatment, resulting in improved breast cancer prognosis. The Lifestyle, Exercise, and Nutrition Early after Diagnosis (LEANer) study is testing the effect of a nutrition and physical activity intervention on chemotherapy completion rates.

methods172 women with stage I-III breast cancer undergoing chemotherapy will be randomized 1:1 to a yearlong, 16 session, nutrition and exercise intervention or usual care control group. The intervention is delivered by registered dietitians specializing in oncology nutrition and exercise training. The intervention includes goal setting to meet nutrition and physical activity guidelines for cancer survivors. After each chemotherapy session, date and dose of each drug administered, and reason for dose-adjustments and/or dose-delays are abstracted from the electronic medical record or obtained from the treating oncologist. Chemotherapy completion rate is assessed as the average relative dose-intensity (RDI) for the originally planned regimen based on standard formulas. Secondary endpoints of endocrine therapy adherence, treatment-related side effects, and changes in inflammatory and metabolic biomarkers, body composition, and patient reported outcomes are assessed at four timepoints. DISCUSSION: If successful, this study has the potential to make healthy lifestyle interventions a standard component of breast cancer treatment.

Indexed as

Breast NeoplasmsDiet, HealthyExerciseFemaleHumansLife StyleQuality of LifeRandomized Controlled Trials as TopicBreast cancerChemotherapy completionExerciseLifestyleNutritionRelative dose intensity

Identifiers

PMID34274495
PMCPMC10424280
OpenAlexW3183390831

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.